Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Studies on the antithrombotic action of AT1 receptor antagonists.

Władysław Buczko, Tomasz Matys, Robert Pawlak, Iwona Kucharewicz, Ewa Chabielska

Med Sci Monit 2001; 7(4): BR600-605 :: ID: 421097

Abstract

Background: In our previous experiments we showed that the prototype memberof the AT1 receptor antagonists (AT1-As) family, losartan, prevented the development of arterial andvenous thrombosis in rats. Recent studies have demonstrated that apart from blocking AT1 receptor, losartanis also a competitive antagonist to thromboxane A2/prostaglandin H[sub]2[/sub] receptor (TP receptor). Thus, wedecided to assess if this feature could contribute to the antithrombotic action of losartan.
Material and methods: We compared the influence losartan, its active metabolite EXP3174 and valsartan on rat plateletadhesion to fibrillar collagen and platelet aggregation in response to thromboxane A2 analogue, U46619.We also assessed the efficacy of these drugs in platelet-dependent pulmonary thrombosis in mice as wellas preventive and therapeutic models of venous thrombosis in rats.
Results: All the three compounds,given in a single dose, inhibited rat platelet adhesion to fibrillar collagen and platelet aggregationinduced with U46619 in vitro and ex vivo, with the action of losartan being much more pronounced thanthat of EXP3174 or valsartan. Losartan also more effectively protected mice from death in response tothe intravenous injection of collagen / epinephrine and it was the only compound which reduced mice mortalityafter the intravenous injection of U46619. In contrast, all the three AT1 receptor antagonists exerteda similar thrombolytic action and comparably decreased the thrombus weight in the therapeutic and preventivemodel of venous thrombosis, although in the latter case a high dose of losartan was slightly more effectivethan a corresponding dose of EXP3174 and valsartan.
Conclusions: Since losartan is endowed with a relativelylow affinity towards the AT1 receptor, we conclude that its superiority over EXP 3174 and valsartan ininhibiting thrombocyte function and platelet-dependent thrombosis could result from its stronger actionon the TP receptor. This feature seems to be less important in the thrombolytic effect of AT1-As andin the inhibition of the venous thrombosis development, in which platelets play only a minor role.

Keywords: AT1 receptor antagonists, Platelet, Thrombosis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750